Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_701_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
55 Мб
Скачать
286
M. Sakr
including compressive symptoms, hoarseness, dys­phagia, and importantly, cancer [32, 33], the inci­dence of which approaches that of patients with a solitary thyroid nodule (STN) [34].
12.2.2 Pathogenesis
Pathogenesis of MNG mainly describes two con­cepts; the I2-deciency goiters (endemic goiters) and the non-I2-deciency goiters (sporadic goiters) [35]. In I2 deciency, less thyroid hormones are pro­duced. A feedback mechanism leads to increased TSH production and consequently to proliferation of thyroid follicles [27] resulting in hypertrophy and hyperplasia of the thyroid gland in a diffuse and homogenous manner [36]. In contrast, in nodular goiter, nodules are surrounded by normal and con­nective tissue suggesting that they result from het­erogeneity of growth [35]. Autonomous growth may occur in toxic and in euthyroid nodular goiter depending on whether the gland produces excessive amounts of hormones or not [37].
In general, the pathogenetic mechanisms of goiter include iodine deciency, autonomy, immunological thyropathy, thyroiditis, cyst for­mation, hematoma, trauma, tumors, neoplastic production of TSH or TSH analog, acromegaly, hormonal resistance, enzyme deciency, involve­ment of thyroid gland in extra-thyroid/systemic diseases, and goitrogenic substances. Other pos­sible factors leading to the development of nod­ules, even in the absence of I
deciency, are the
2
epidermal GF and the insulin-like GF [38].
For prophylaxis of endemic goiter in I2­decient areas, supplementation with 150μgI2/ day is recommended for adults and is increased in pregnancy to 200μg I2/day. This dose should be adjusted for children to 50μg for the rst year of life, 90μg for ages 1–6years, and 120μg for ages 7–12years [39, 40].
12.2.3 Clinical Assessment
12.2.3.1 Patient’s History
The patient’s history may be without complaint or may, apart from an awareness of the goiter size, include a globus sensation, dysphagia, dys-
pnea, choking, or stridor. The rate of growth over time as well as symptoms of hypo or hyperthy­roidism must be evaluated. Symptoms of hyperthyroidism include increased appetite, weight loss, heat intolerance, nervousness, irrita­bility, agitation, palpitation, diarrhea, muscular weakness (myopathy) as well as oligo-/dys­menorrhea. On the other hand, the main symp­toms of hypothyroidism are weight gain (myxedema), depression, concentration weak­ness, cold intolerance, fatigue, constipation, and oligo-/amenorrhea [39].
12.2.3.2 Physical Examination
Palpation of the thyroid gland is performed from the back of the patient. Typically, it moves up with deglutition. The size of the gland is evalu­ated, nodules are palpated (Fig. 12.2a–d), and signs of local compression are assessed. Retro­sternal goiter (RSG) may not be visible on clini­cal examination and may be unrecognized for many years. It may cause superior vena caval obstruction. Additionally, cervical LNs should be examined for size, consistency, and mobility, which may indicate malignancy.
Signs of “hyperthyroidism” may include tachycardia, tachyarrhythmias (extra-systoles, atrial brillation or utter), hyperreexia, ne tremors, warm and moist hands, soft and ne hair as well as hair loss. “Thyrotoxic crisis/coma” is a severe condition of untreated exacerbated hyper­thyroidism that may occur in Graves’ disease, autonomous adenoma, or multinodular toxic goi­ter. It presents with tachycardia, tachyarrhyth­mia, hyperthermia, diarrhea, vomiting, dehydration, muscular weakness, excitation (grade 1), disorientation, hallucination, somno­lence (grade 2), and coma (grade 3).
Signs of “hypothyroidism” include bradycar­dia, hypotension, cardiac insufciency, slow ten­don reexes, dry, pale, cold, rough and doughy skin (myxedema), rough hair, and a hoarse voice. Myxedema coma frequently occurs after chronic untreated hypothyroidism with acute exacerbation due to infection, operation, severe general disease, cold, or sedative. It presents with somnolence, severe hypothermia, hypotension, bradycardia, hypoventilation, hyponatremia, hypoglycemia, and possible pericardial and pleural effusion.
t.me/Dr_Mouayyad_AlbtousH
ab
cd
12 Benign Thyroid Disease
287
Fig. 12.2 (a) A 28-year-old lady with an enlarged thy- roid gland. Note the nodular appearance. (b) Huge goiter in a 58-year-old lady. Note the multinodular appearance. (c) Large goiter in a 67-year-old lady. Note the multinodu-
12.2.4 Complications ofMultinodular Goiter (MNG)
lar appearance with the largest in the left lobe. (d) Large mulit-nodular goiter in a 64-year-old lady affecting mainly the right lobe
most important complication, which usually occurs in long-standing cases. The clinical crite­ria of malignant transformation are listed in
Neglected or untreated MNGs may present with
Table12.4.
complications, which include the following:
12.2.4.3 Compression Manifestations
12.2.4.1 Toxicity
Secondary thyrotoxicosis may develop in 10–20% of cases, usually above the age of 30years. Toxic nodular goiter is treated by sur­gery after patient preparation.
12.2.4.2 Malignant Transformation
The development of papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) is the
The pressure manifestations may result from the rapidly enlarging thyroid, retro-sternal extension, malignancy, or hemorrhage. The sequelae will depend on the structures compressed (or inltrated):
Trachea: Dyspnea results from displacement
of the trachea to one side by an enlarging uni­lateral goiter, compression from both sides in
t.me/Dr_Mouayyad_AlbtousH
288
M. Sakr
Table 12.4
of a multinodular goiter
Glandular criteria Extra-glandular criteria – Rapid recent growth
– Fixation of the
– Consistency
– Edges become
– Onset of pain
Clinical criteria of malignant transformation
– Compression
symptoms become swelling—restricted mobility with deglutition
becomes harder
ill-dened
more evident
– Vocal cord paralysis
due to inltration of the recurrent laryngeal nerve (RLN)
– Horner’s syndrome due
to inltration of the
cervical sympathetic
trunk
– Cervical lymph node
(LN) enlargement
– Unequal carotid
pulsations
bilateral goiters (scabbard trachea), or tra­cheomalacia (softening of trachea) in long­standing cases.
Esophagus: Dysphagia; however, this usually
results from inltration rather than compres­sion and thus should alert the physician to the possibility of cancer.
Neck veins: the patient presents with mediasti-
nal syndrome and congested face.
RLN: hoarseness of voice mostly occurs due
to malignant inltration rather than just pres­sure on the nerve.
12.2.4.4 Calcication
In long-standing cases, calcication may occur either in the capsule or in the septa. Plain radiog­raphy is diagnostic. It results in a “hard” nodule and may be mistaken clinically for malignancy.
12.2.4.5 Cyst Formation
Development of cysts/pseudocysts in MNGs results from rupture of neighboring acini, hemor­rhage, infection, or degeneration of nodules.
12.2.4.6 Hemorrhage
Bleeding may occur suddenly, precipitated by straining, causing sudden increase in the size of the gland, pain in the neck, and sudden compres­sion of the trachea with impending suffocation augmented by reex spasm of pretracheal mus­cles. Urgent treatment is necessary to relief com-
pression immediately by aspiration of the cyst, division of the pretracheal fascia, incision, and evacuation of the hematoma. Urgent thyroidec­tomy is performed to remove the hemorrhagic nodule.
12.2.4.7 Infection
Multinodular goiters rarely get infected, but infection has been reported to occur in a MNG more commonly than in a normal gland.
12.2.5 Investigations
12.2.5.1 Laboratory Findings
The most important parameter is the basal TSH serum level. It is normal in the euthyroid state. If not, fT4 and fT3 should be performed. If an auto­immune process is suspected, thyroid autoanti­bodies should be tested such as the anti-thyro-peroxidase (TPO) and anti-TSH receptor antibodies. It must be noted that they may also be positive in healthy individuals or patients with goiter or autonomy [38].
12.2.5.2 Imaging Findings
Ultrasonography (US)
All patients scheduled for thyroid (or parathy­roid) surgery should undergo a preoperative ultrasound (US). It is the most precise tool for evaluating the thyroid and nodule size [38]. The normal volume of the thyroid is 7–20 mL and nodules larger than 2 mm in diameter may be identied [41]. Besides the size, US provides valuable information regarding echogenicity (the normal thyroid is iso-echogenic or slightly hyper­echogenic), nodular composition as it allows dif­ferentiation between solid nodules and simple or complex cysts, presence of calcications (micro i.e., 1mm or less, or macro), as well as shape and margins. Moreover, US may differentiate extra­thyroidal structures from the thyroid gland and may give information on regional lymphadenop­athy [42].
Color-ow Doppler US gives further informa­tion on vascular ow and velocity. In addition, FNAC under US guidance improves the accuracy
t.me/Dr_Mouayyad_AlbtousH
12 Benign Thyroid Disease
289
of palpation-guided FNAC and allows FNA cyto­logical sample from a “suspicious” nodule.
Scintigraphy
Scintigraphy has become rare due to the progress in US techniques. It should be performed only if it has an impact on the therapeutic plan, for instance in a young patient with a STN, possibly a carcinoma, or in case of hyperthyroidism [38]. According to scintigraphy, thyroid nodules may be “hot” in the presence of autonomously func­tioning thyroid tissue (rarely malignant) or “cold” in which case the incidence of malignancy is 10–20% [43]. Cystic nodules are usually “cold.”
Radiography andTomography
Plain chest X-rays may show a substernal goiter (Fig.12.3), and CT scan and MRI are indicated for large tumors extending to adjacent structures such as the mediastinum or the retro-pharyngeal region [43].
12.2.5.3 Fine-Needle Aspiration (FNA)
For evaluation of the potential malignancy of a nodule, US-guided FNAC may give further infor­mation. Indications are suspected malignancy with the following ndings: young patient, previ­ous radiation exposure of the neck, rapid growth, cold in scintigraphy, and US ndings of
Fig. 12.3 Plain X-ray of the chest showing a mediastinal soft tissue shadow; retro-sternal goiter (arrow)
hypo- echogenicity, loss of halo, size >1cm diam­eter, ill-dened margin, and the presence of micro- calcications, in addition to hypervascu­larity on Doppler examination, and the presence of enlarged cervical LNs (suspicious) [39].
12.2.5.4 Airway Assessment
Signs of signicant airway obstruction are stri­dor, labored breathing, intercostal retractions, and agitation in case of RSG vena caval obstruc­tion [44]. Indirect laryngoscopy may be helpful and should be a routine examination [45], partic­ularly in repeat surgery for recurrent goiter or if there is evidence of RLN dysfunction. A chest X-ray is evaluated for tracheal deviation and compression [46]. Other examinations, such as CT and MRI, are not routinely performed but may give additional information, especially in cases of RSG [47]. Respiratory function tests are debat- able [48]. In patients with evidence of a compro­mised airway, the airway is assessed using beroptic laryngoscopy after the application of topical anesthesia and oxygen [44].
12.2.6 Management ofMNG
12.2.6.1 Nonoperative Treatment
Conservative treatment of MNG with L-thyroxin (L-T4) may be effective or at least partially, in reducing the volume of relatively small, benign, solitary, solid thyroid nodules [4953]. Low­TSH suppression is effective in reducing nodule volume [28]. However, some authors reported a volume reduction without treatment, probably due to spontaneous regression [47, 50].
Alternatively, radioactive iodine (RAI) ther­apy may be used in elderly patients or those with contraindications for surgery [54]. The lifetime risk of cancer due to RAI is negligible in patients over 65years old.
In Graves’ disease, surgery, RAI therapy, and treatment with anti-thyroid drugs (ATDs) are all options, whereas autonomy is a classical indica­tion for radiotherapy except in solitary autono­mous nodules where surgery is equally effective. Thyroid neoplasms are an indication for surgery as are I2-induced hyperthyroidism and intractable
t.me/Dr_Mouayyad_AlbtousH
290
M. Sakr
hyperthyroidism not responsive to conservative management [38].
12.2.6.2 Surgical Treatment
Indications andExtent ofSurgery
Indications for surgery of the thyroid gland vary depending on the pathology: in euthyroid MNG, the main indications are goiter size, compression symptoms, and suspected malignancy. Various surgical options exist, ranging from hemithy­roidectomy (lobectomy) to total thyroidectomy (if the thyroid gland contains nodules throughout).
Because of a reportedly high-frequency com­plications in some series, controversy exists about the routine use of total thyroidectomy (TT) for the management of “benign” MNG [5559]. However, it is noteworthy that, when performed by experienced hands, TT, compared with subto­tal resection, does not increase morbidity in benign pathologies [5863]. In cases of retroster­nal goiter (RSG), TT is preferred owing to the malignant potential and in order to reduce the recurrence rate (RR) [64]. It is important to emphasize that proper training and surgical expe­rience are signicantly associated with low com­plication rates in thyroid surgery [65, 66].
Multinodular Goiter (Benign/Thy 2)
Patients with MNG, diagnosed with FNA as being benign (Thy 2) could either receive deni­tive surgery or annual monitoring with TSH lev­els (Table12.5).
Table 12.5 Indications of surgery and annual TSH­monitoring for patients with MNG (Thy 2)
Indications of surgery – Compression
syndrome – Cosmetic reasons – Follicular or Hurthle
cell lesion (Thy 3) – Concern about
malignancy (Thy 4) – Persistent
troublesome toxic
nodules
Indications of annual TSH monitoring
– The goiter is small or
modest in size
– The patient is
euthyroid with normal TSH
– Clinically asymptomatic
without signs of compression
– FNAC of all
suspicious nodules is benign
Thyroid Nodules Associated withHypo-/ Hyperthyroidism
These nodules are very unlikely to be malignant. They are more likely to be benign toxic nodule or Hashimoto’s thyroiditis. The frequency of malig­nancy in cold nodules is 10–20% and only 4% in hot nodules [67, 68]. These nodules should still be aspirated and if conrmed to be benign (Thy
2) after two aspirates 3–6months apart, with no other suspicious features, can be safely managed by an endocrinologist, and referred back for re­evaluation if there are any change in the swelling.
Dominant Nodule inMNG
Patients with hyper- or hypothyroidism associ­ated with MNG with no other suspicious features in history and clinical examination have a low risk of thyroid cancer [24]. When a “dominant nodule” is noted to be growing and become sus­picious, it should be aspirated and treated accord­ing to cytology results. Patients at low risk, who are euthyroid with MNG of long duration and slow growth, have a very low risk of thyroid can­cer [24]. Patients can be observed at intermediate or long intervals.
Thyroid Cystic Swelling
It should be clearly stated that in order to help the pathologist in interpreting FNAC, the cyst should be aspirated to dryness under US-guidance, and any residual mass should be noted and subjected to FNAC immediately as a separate specimen [24]. For a thyroid cyst that is shown to be benign on FNAC and does not recur at follow-up, clini­cal observation alone may be sufcient. A recur- rent thyroid cyst should be re-aspirated during follow-up and the sample sent for cytology. Patients with high-risk factors in history and clin­ical examination can be considered for diagnostic lobectomy. Some surgeons would consider diag­nostic lobectomy for a cyst that has recurred for three times or more. Surgery can also be consid­ered at patient’s request.
Results ofSurgical Treatment ofMNG
The rate of secondary hemorrhage is approxi­mately 1%, whereas the rate of persistent RLN
t.me/Dr_Mouayyad_AlbtousH
12 Benign Thyroid Disease
291
paresis and of hypoparathyroidism has dropped to <1% in the last 2 decades [69, 70]. Adequate surgery is part of the prophylaxis of recurrence [71]. In a case-control study, young age and mul­tiple nodules at initial surgery have been identi­ed as independent risk factors of recurrence [57]. Despite suppressive L-T4 treatment postop­eratively, 14% of patients develop recurrence after subtotal thyroidectomy (STT) after a median follow-up of 14.5 years [72]. Without suppres­sion, the RR reaches up to 41% [73, 74]. Recently, TT is being increasingly accepted and recom­mended for the treatment of MNG [60, 75].
Prophylaxis ofRecurrence
In addition to adequate surgery, postoperative sup­pression therapy with the proper dose of L-T4 is important for preventing recurrence [71]. In I2­deciency goiter with no substitution, 25% of patients will have a recurrence. The aim should be a TSH in the lower normal range (0.3–1mU/L), in contrast with malignancies where the TSH should be suppressed to <0.1mU/L.Strong TSH suppres­sion, however, increases the risk of cardiac com­plications and accelerates osteoporosis [76, 77].
Treatment ofRecurrent Goiter
Surgery for recurrent goiter has a higher compli­cation rate than in the primary setting [33, 64], with signicantly higher temporary and perma­nent RLN palsy (5% and 3%, respectively) [78]. The indication is therefore restricted to suspicion of malignancy. Preoperatively, indirect laryngos­copy for RLN function is essential. Intra­operative nerve monitoring may be helpful in identication of the nerve [46]. If preoperative unilateral RLN paresis is present, if possible, only ipsilateral hemithyroidectomy should be considered [71].
12.3 Retro-sternal Goiter (RSG)
12.3.1 Introduction
Terms such as retro-sternal, sub-sternal, intra­thoracic, or mediastinal have been used to
describe a goiter that extends beyond the connes
of the neck into the thoracic cavity. However, there is lack of consensus regarding the exact denition of a retro-sternal goiter (RSG) [64,
7986]. Although the great majority of RSGs are
extensions from the neck, rarely (<1%), pure intra-thoracic goiters do occur.
Most of these goiters are slow growing and often do not cause symptoms until the mass reaches a critical size and causes compression symptoms. Although the majority of these lesions are benign in nature approximately 6–16% may be malignant, and a few cases may exhibit thyro­toxicosis [8790]. Usually, malignancy must be ruled out when RSGs are discovered in asymp- tomatic individuals. Because FNA is often dif­cult or inadvisable in this location, many authors have advocated surgical removal of all RSGs even when asymptomatic. Very rarely, a left- sided cer­vical goitre descends into the right side of the chest this is called a “crossed sub-sternal goiter.”
Controversies exist regarding the incidence of tracheomalacia in RSG, with its anesthetic and surgical implications. Superior vena cava (SVC) with variable incidence and signicance has been associated with RSG. Even more importantly, from a surgical point of view, the approach required for an RSG is still a subject of signi­cant debate.
12.3.2 Denitions ofRetro-sternal
Goiter (RSG)
There are several denitions of RSG in the litera­ture as follows:
– In 1957, Goldenburg and Lindskog [91]
dened RSG as “one reaching the level of the
fourth thoracic vertebra on chest X-ray.”
– In 1994, Singh and co-workers [85] suggested
that RSG was “when >50% of the goiter was
below the plane of the thoracic inlet”
– In 1998, Vadasz and Kotsis dened RSG as “a
thyroid gland reaching the level of the aortic
arch” [92].
– In 2006, Wu etal. [93] described three types of
RSG according to clinical features and thyroid
position; type I goiters, when the lower pole of
t.me/Dr_Mouayyad_AlbtousH
292
the gland is over the arch of the aorta; type II goiters are those below the arch of the aorta and extending into the posterior mediastinum, while type III are giant goiters located in the chest or when the patient present with SVC syndrome.
– In 2007, Candela et al. [94] dened RSG as
“any goiter that descended below the plane of the thoracic inlet or growing into the anterior mediastinum for >2cm with the patient in the surgical position.” This is the generally accepted denition.
– In 2008, White and co-workers [82] dened
RSG as “any goiter, which required dissection in the mediastinum.”
12.3.3 Incidence
The exact incidence of RSG is generally difcult to assess, but reportedly ranges from 1.7 to 21% of patients undergoing thyroidectomy [8890,
92, 95], and represents up to 7% of mediastinal
tumors, ranging from 5 to 19% [80, 88]. Usually, patients with RSG are in their fth decade of life; however, patients as young as 15years and old as 90 years were reported [80]. The female:male ratio is 3:1 or 4:1 [96]. Approximately, 5–40% of patients with RSG are “asymptomatic.” Tracheomalacia has been reported in 0–10.3% of patients with RSG and accounts for the majority of tracheostomies performed in 0–8.6% of these patients [82]. The incidence of cancer in patients with RSG is reported to be between 2.5% and 21%. A recent review of evidence-based manage­ment of RSGs concluded that the incidence of malignant transformation is equivalent in RSGs to those residing entirely in the neck [82].
M. Sakr
Fig. 12.4 Primary retrosternal goiter: intra-thoracic goi­ter originating in the chest Blood supply is derived from intra-thoracic vessels
STA
ITA
12.3.4 Anatomical Classication
The location of RSGs is the superior mediasti­num, either anteriorly [80, 97] or posteriorly [97,
98]. They are classied as either “primary”
(Fig.12.4) or “secondary” (Fig.12.5) goiters.
t.me/Dr_Mouayyad_AlbtousH
Fig. 12.5 Secondary retrosternal goiter: originating from the left thyroid lobe. STA: superior thyroid artery; ITA: inferior thyroid artery
12 Benign Thyroid Disease
293
12.3.4.1 Primary RSG (Intra-thoracic—Aberrant)
Primary mediastinal or RSGs (also named aber­rant) are those without any direct connection to
the cervical thyroid gland. Further denitional criteria include (1) blood supply from a mediasti­nal (not cervical) source, (2) a normal or absent cervical thyroid gland, (3) no history of prior thy­roid surgery, and (4) a lack of similar pathology in the other portions of the thyroid gland. It accounts for <1% of all RSGs and originates from ectopic (accessory) embryonal thyrocytes that have descended into the chest with the arch of the aorta [82, 99, 100].
12.3.4.2 Secondary RSG (Mediastinal Plunging)
Secondary RSGs constitute the majority of the cases. They are cervical goiters that have migrated to the intra-thoracic location favored by many factors. These include (1) the increasing weight of the thyroid gland, (2) negative intra-thoracic pressure, (3) respiratory movement, (4) swallow­ing, (5) shortness of the neck, and (6) absence of anatomical structure that anchors the thyroid between the lower neck and the thoracic inlet [87]. Secondary RSGs receive their blood supply from the superior and inferior thyroid arteries (ITAs) [82, 100].
Approximately, 75–90% lie in the “anterior” mediastinum, usually originating from the lower pole of the thyroid gland and descend along the antero-lateral aspect of the trachea and anterior to the RLN and carotid vessels [87, 101]. Occasionally (10–15%), a goiter originating from the postero-lateral aspect of the thyroid may descend into the “posterior” mediastinum push­ing the esophagus to the opposite side and causing forward displacement of the trachea and tilting of the larynx. In this case, the RLN, ITA, and carotid vessel lie anterior to the goiter [64].
A goiter, which arises from the left lobe, may descend to the right due to the presence of major vessels and is termed “crossed RSG.” A goiter that rises in the neck with deglutition and then descends again is termed “plunging goiter.”The main differences between the primary and sec­ondary RSGs goiter are shown in Table12.6.
Table 12.6 Differences between primary and secondary retros-ternal goiters (RSGs)
Differences Primary RSG Secondary RSG Origin Ectopic
Blood supply
Connection with cervical thyroid gland
Cervical mass None Yes in 80–90% of
thyroid tissue in the chest
Intra­thoracic aorta
None Usually contiguous
Extension of cervical thyroid into the chest
Inferior thyroid artery
with the cervical gland or connected by a brous band
patients
12.3.5 Clinical Manifestations
12.3.5.1 Symptoms
Usually, patients are in their fth decade of life, with a female to male ratio of 3–4:1. Approximately, up to 40% of patients are asymp­tomatic for many years [102, 103], with inciden­tal discovery on X-ray revealing a mediastinal mass or tracheal deviation [84, 104].
A neck lump is present in up to 65% of patients. Other symptoms are the result of com­pression of intra-thoracic structures (airway, esophagus, blood vessels, or nerves), separately or in combination [87, 101]. Compression of the airway occurs in about 32–50% of patients and may present with dyspnea, stridor, or a choking sensation [90, 96, 105, 106] and may require urgent intubation or a semi-urgent operation in 22% [90]. In some patients, dyspnea is experi­enced only when the head is turned toward one side or by lying down at. Dysphagia is present in about 30–40% being more common with RSGs located in the posterior mediastinum. Hoarseness of voice is reported in approximately 13% of patients [64, 81, 88, 104]. A rare neurological presentation that may occur is Horner’s syn­drome (meiosis, anhiderosis, and ptosis) [107]. Unusual symptoms result from vascular com­pression causing downhill upper gastrointestinal bleeding from esophageal varices, effort axillary vein thrombosis, transient ischemic attacks (TIA), and cerebral edema. Hyperthyroidism may be observed in cervical or RSGs, resulting
t.me/Dr_Mouayyad_AlbtousH
294
M. Sakr
from an autonomously functioning nodule or may be precipitated by ingestion of iodides found in certain expectorants or radiographic contrast media [64, 81, 88, 104].
12.3.5.2 Physical Examination
A palpable lump in the neck, with impalpable lower border and dull sternal percussion, may be demonstrated in about 80–90% of patients [88]. Other signs include dilated neck and chest veins (Fig. 12.6) and tracheal deviation. Raising the arms or hyperextension of the neck may cause dilatation of cervical veins and ushing of the face or even respiratory difculty/stridor (Pemberton’s sign). Although no specic inci­dence of thyrotoxicosis is reported in patients with SSG, it is expected not to be different from that incidence of totally cervical nodular goiter. Common signs and symptoms of RSG are sum­marized in Table12.7.
12.3.6 Diagnosis
12.3.6.1 Laboratory Studies
The following blood tests can be helpful pre­operatively: thyroid function tests (TSH, free T4), calcium, albumin and parathyroid hor­mone (PTH). TSH and FT4 are used to assess thyroid hormone production and the need for
preoperative treatment of hyperthyroidism or thyroid hormone replacement in cases of hypo­thyroidism. Calcium, with albumin correction, and PTH can help predict the need for calcium (and vitamin D) replacement after thyroidectomy.
12.3.6.2 Pulmonary Function Tests/
Flow-Volume Loops
Pulmonary function studies may indicate the presence and level of airway obstruction and serve as a baseline to measure improvement after thyroidectomy (Fig.12.7) [96].
12.3.6.3 Plain Chest X-Ray (CXR)
Plain CXR is the most “cost-effective” method for diagnosis of RSG.Findings include deviation and/or compression of the trachea (Fig. 12.8), soft tissue density or a mass, and occasionally calcications (Fig.12.9).
12.3.6.4 Computed Tomography (CT)
Scan andMagnetic Resonance Imaging (MRI)
Both, CT scan (Fig.12.10) and MRI (Fig.12.11) can provide more precise information about the relationship between the various intra-thoracic organs and the goier. This information helps the surgeon to plan for both the intubation and opera­tion [96, 108].
Fig. 12.6 Venous congestion and dilatation of the neck and upper chest veins due to obstruction by a large retrosternal goiter in a 51-year-old patient
t.me/Dr_Mouayyad_AlbtousH
Table 12.7
RSG
Symptoms Signs
• Asymptomatic
• Neck lump
• Compression – Airway: dyspnea,
Esophageal: dysphagiaNerve: hoarseness of
Vascular: SVC
SVC superior vena cava; TIA transient ischemic attack; GI gastrointestinal
Clinical symptoms and signs of patients with
• Cervical mass
• Dilated veins of the neck
stridor, raspy cough, wheezing, chocking
voice, Horner’s syndrome
syndrome, TIA, cerebral edema, GI bleeding
• Tracheal deviation
• Flushing of skin
• Pemberton’s sign
• Horner’s syndrome
5
Flow (L/s)
-4
12 Benign Thyroid Disease
4
3
2
295
1
0
-1
-2
-3
Expiration
Inspiration
Before therapy
Fig. 12.7 Flow volume loops (shown schematically) of a patient (stippled curves) with a large RSG before (left
panel) and 12 months after (right panel) therapy. The solid curves represent a subject with normal lung func-
Expiration
Inspiration
After therapy
tion. Tracheal compression by RSG causes upper airway obstruction, which primarily affects the inspiratory capac­ity, as indicated by the arrows
Fig. 12.8 Chest X-ray showing left tracheal deviation (arrow) by a retrosternal goiter (RSG)
Fig. 12.9 Plain X-ray showing calcication in a retroster­nal goiter with right tracheal deviation
t.me/Dr_Mouayyad_AlbtousH